SCHEMBL7044202

SCHEMBL7044202

CCCC(=O)OC(=O)Oc1cc(C(=O)Cc2ccccc2)cc([N+](=O)[O-])c1OC(=O)OC(=O)CCC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
PKM P14618 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
THRA P10827 1/20 0.36
THRB P10828 1/20 0.36
BCL9 O00512 1/20 0.36
CTNNB1 P35222 1/20 0.36
GRM1 Q13255 1/20 0.35
ALDH1A1 P00352 3/20 0.35
LMNA P02545 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7049743 0.90 BCL9 (0.41) CA12CA1CA2CA9NPC1
SCHEMBL7048480 0.81 TOP1 (0.42) CA12CA1CA2CA9NPC1
SCHEMBL7046037 0.72 NPC1 (0.43) NPC1RAB9APKML3MBTL1ALDH1A1
SCHEMBL7048078 0.72 TTR (0.52) NPC1RAB9AL3MBTL1ALDH1A1LMNA
SCHEMBL7046245 0.71 NPC1 (0.45) NPC1RAB9AALDH1A1LMNAGAA
SCHEMBL4293802 0.69 NPC1 (0.65) NPC1RAB9AALDH1A1LMNAMAPT
SCHEMBL7049065 0.69 ALDH1A1 (0.43) CA12CA1CA2CA9NPC1
SCHEMBL7429291 0.68 BCL9 (0.41) L3MBTL1BCL9CTNNB1ALDH1A1LMNA
Nebicapone SCHEMBL29379610 0.67 TTR (0.56) RAB9ATHRBALDH1A1LMNAKDM4E
Nebicapone SCHEMBL132167 0.67 TTR (0.56) RAB9ATHRBALDH1A1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1010688-B1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them PORTELA & CA SA (PT) 2003-04-09 EP disclosed
US-6512136-B1 Hypotensive, antiedemic agents; gastrointestinal disorders; Parkinson*s disease treatment PORTELA & C.A., S.A. (PT) 2003-01-28 US disclosed
EP-1010688-A1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them Portela & Ca., S.A. (PT) 2000-06-21 EP disclosed